- Regions Financial Corporation stock price today and history
Regions Financial Corporation (RF) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
Regions Financial Corporation stock price
Regions Financial Corporation latest news:
Stocks end volatile session lower as rally collapses in wake of Fed minutes
U.S. stocks ended a volatile session on a downbeat note on Wednesday, as an afternoon rally quickly fizzled in the wake of the Federal Reserve releasing the minutes to its most recent meeting. The Dow Jones Industrial Average fell 168 points, or 0.7%, to 24,797. The S&P 500 lost 15 points to 2,701, a drop of 0.6%. The Nasdaq Composite Index sank 16 points, or 0.2%, to 7,218. All three had been solidly higher in afternoon trading, but they sharply retreated as investors struggled to digest the minutes, which pointed to a strong economy, but also the "increased likelihood" of more rate hikes ahead. The news pushed the U.S. dollar higher and sent the yields for the 10-year Treasury note to a four-year high of 2.95%. Recent trading on Wall Street has been driven by the prospect of inflation returning to the economy, and the Fed having to become more aggressive in raising rates to combat such a scenario. One bright spot for markets was banks, which typically do well in rising-rate environments due to the positive impact it has on their net interest margins. Among notable gainers, Citigroup Inc. rose 0.7% while Zions Bancorp was up 1.6%. Regions Financial closed up 1.1%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Regional bank ETF on track for record close in wake of Fed minutes
Exchange-traded funds that track the banking sector surged on Wednesday, after minutes from the Federal Reserve's most recent meeting pointed to higher odds for more rate hikes going forward. The SPDR S&P Regional Banking ETF added 1.8% and was on track for a record close. Separately, the SPDR S&P Bank ETF jumped 1.8% and was on track for its highest close since late January, which itself represented its best close since 2007, before the worst of the financial crisis. The fund is up 7.9% thus far this year, easily outperforming the 2.7% rise of the S&P 500, while the regional bank fund has gained 8.3% in 2018. The Fed's minutes showed that officials saw a stronger economy than at the end of last year, and that strength "increased the likelihood that a gradual upward trajectory of the federal funds rate would be appropriate." Bank stocks tend to do well in rising-rate environments, given the impact it has on their net interest margins, or the difference between the interest they earn on the loans they make and the interest they pay out. Low margins can lead to lower earnings. Among specific stocks, Bank of America rose 1.2% while Citigroup Inc. added 2.4%. On the regional side, Zions Bancorp was up 2.7% and Regions Financial Corp. was up 2.3%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
BRIEF-Regions Financial Corp. Director David Cooper Sr. To Retire
Regions Financial Corp(RF): * Regions Financial Corp(RF). DIRECTOR DAVID J. COOPER SR. TO RETIRE. * Regions Financial Corp(RF). DIRECTOR DAVID J. COOPER SR. TO RETIRE. * Regions Financial Corp(RF) - DAVID COOPER SR. WILL RETIRE FROM COMPANY'S BOARD OF DIRECTORS EFFECTIVE APRIL 25, 2018 Source text for Eikon: Further company coverage:
Teva shares rise 4% on major reorganization, leadership changes
Teva Pharmaceutical Industries Ltd. shares rose 4% in Monday morning trade after the company announced a major reorganization and several top leadership changes. Cheap generic drug prices have put significant pressure on the generic drugmaker in recent months, and the changes -- under new Chief Executive Kare Schultz -- were described as a way to take "decisive and immediate action to address external pressures and internal inefficiencies," according to a statement by Schultz. Teva, which previously organized its generics and specialty drug businesses in two separate units, will now instead operate through three regions -- North America, Europe and Growth Markets -- that will manage all Teva drugs "with full end-to-end P&L accountability," the company said. Some of Teva's previous business units will be retained, but not all, Teva said. Leadership changes include the retirement of Michael Hayden, president of global research and development, Rob Koremans, president and chief executive of global specialty medicines, and Dipankar Bhattacharjee, president and chief executive officer of the global generic medicines group, at the end of the year. The company's new management team includes now-Chief Financial Officer and Executive Vice President Michael McClellan, Executive Vice President, Global R&D Hafrun Fridriksdottir, Executive Vice President, North America Commercial Brendan O'Grady, Executive Vice President, European Commercial Richard Daniell, Executive Vice President, Growth Markets Commercial Gianfranco Nazzi and Executive Vice President, Global Marketing & Portfolio Sven Dethlefs. Teva shares have dropped 13% over the last three months and 61% year-to-date, compared with a 6.5% rise in the S&P 500 over the last three months and a 8% rise in the Dow Jones Industrial Average .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Regions Financial CorporationRF^A
Regions Financial CorporationRF^B
Reinsurance Group of AmericaRGA
Reinsurance Group of AmericaRZA
Reliance Steel & Aluminum Co.RS
RenaissanceRe Holdings Ltd.RNR
RenaissanceRe Holdings Ltd.RNR^C